Max Planck Society Ends Elsevier Subscription

The move is a show of support for Project DEAL and the open-access movement.

| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

ABOVE: Max Planck Institute for Biophysics
© ISTOCK.COM, OLLO

The Max Planck Society, an enormous German research organization 14,000 scientists strong and comprising multiple research institutes, has ended its subscription to Elsevier journals, the organization announced in a statement this Tuesday (December 18). It did so in support of the German open-access initiative called Project DEAL, after unsuccessful attempts to negotiate an open-access agreement with the publisher. The organization’s digital library will no longer have access to Elsevier’s approximately 2,500 journals, including The Lancet and Cell, once the subscription expires on December 31.

“The system of scholarly publishing today is a relic of the print era, and we want to activate a real paradigm shift in order to finally utilise the opportunities of the digital age,” says Gerard Meijer, director of the Max Planck Society’s (MPS) Fritz Haber Institute and a member of the DEAL negotiating team, in the statement.

Project ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Keywords

Meet the Author

  • Ashley P. Taylor

    This person does not yet have a bio.
Share
May digest 2025 cover
May 2025, Issue 1

Study Confirms Safety of Genetically Modified T Cells

A long-term study of nearly 800 patients demonstrated a strong safety profile for T cells engineered with viral vectors.

View this Issue
iStock

TaqMan Probe & Assays: Unveil What's Possible Together

Thermo Fisher Logo
Meet Aunty and Tackle Protein Stability Questions in Research and Development

Meet Aunty and Tackle Protein Stability Questions in Research and Development

Unchained Labs
Detecting Residual Cell Line-Derived DNA with Droplet Digital PCR

Detecting Residual Cell Line-Derived DNA with Droplet Digital PCR

Bio-Rad
How technology makes PCR instruments easier to use.

Making Real-Time PCR More Straightforward

Thermo Fisher Logo

Products

fujirebio-square-logo

Fujirebio Receives Marketing Clearance for Lumipulse® G pTau 217/ β-Amyloid 1-42 Plasma Ratio In-Vitro Diagnostic Test

The Scientist Placeholder Image

Biotium Launches New Phalloidin Conjugates with Extended F-actin Staining Stability for Greater Imaging Flexibility

Leica Microsystems Logo

Latest AI software simplifies image analysis and speeds up insights for scientists

BioSkryb Genomics Logo

BioSkryb Genomics and Tecan introduce a single-cell multiomics workflow for sequencing-ready libraries in under ten hours